Amgen Pharmaceutical Company Planning Developing New Osteoporosis Drug
Amgen NASDAQ: AMGN pharmaceutical company just announced outstanding performance results for denosumab Pivotal Postmenopausal Osteoporosis Trial.
Continue Reading »
:: Aug.05.2008 :: 1160 :: No Comments »
